Future challenges in head and neck cancer: From the bench to the bedside?

Ferlay, 2004 2003, 172 Conway, 2006, Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999) recent trends and regional variation, Oral Oncol, 46, 586, 10.1016/j.oraloncology.2005.10.018 Hashibe, 2009, Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium, Cancer Epidemiol Biomarkers Prev, 18, 541, 10.1158/1055-9965.EPI-08-0347 Psyrri, 2009, Human papillomavirus-related head and neck tumors: clinical and research implication, Curr Opin Oncol, 21, 201, 10.1097/CCO.0b013e328329ab64 zur Hausen, 2009, Papillomaviruses in the causation of human cancers—a brief historical account, Virology, 384, 260, 10.1016/j.virol.2008.11.046 Wittekindt, 2005, Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival, Adv Otorhinolaryngol Basel, 62, 72 Slaughter, 1953, Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer, 6, 693, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Steiling, 2008, The field of tissue injury in the lung and airway, Cancer Prev Res, 1, 396, 10.1158/1940-6207.CAPR-08-0174 Almadori, 2004, Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review, Eur J Cancer, 40, 2383, 10.1016/j.ejca.2004.04.023 Almadori, 2005, Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach, Eur J Cancer, 41, 683, 10.1016/j.ejca.2004.10.031 Marcu, 2009, A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment, J Cancer Res Clin Oncol, 135, 1303, 10.1007/s00432-009-0648-7 Sidransky, 2002, Emerging molecular markers of cancer, Nat Rev Cancer, 2, 210, 10.1038/nrc755 Le, 2003, Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer, Clin Cancer Res, 9, 4287 Spielmann, 2010, 15-Year review of laryngeal and oral dysplasias and progression to invasive carcinoma, Eur Arch Otorhinolaryngol., 267, 423, 10.1007/s00405-009-1013-9 Vogelstein, 2004, Cancer genes and the pathways they control, Nat Med, 10, 789, 10.1038/nm1087 Poeta, 2007, TP53 mutations and survival in squamous-cell carcinoma of the head and neck, N Engl J Med, 357, 2552, 10.1056/NEJMoa073770 Williams HK, 2000, Molecular pathogenesis of oral squamous carcinoma, J Clin Pathol Mol Pathol, 53, 165, 10.1136/mp.53.4.165 Forastiere, 2001, Head and neck cancer, N Engl J Med, 345, 1890, 10.1056/NEJMra001375 Myers, 2000, Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes, Otolaryngol Head Neck Surg, 122, 44, 10.1016/S0194-5998(00)70142-2 Hinerman, 2004, Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience, Head Neck, 26, 984, 10.1002/hed.20091 Ribeiro, 2000, Impact of comorbidity, symptoms, and patients’ characteristics on the prognosis of oral carcinomas, Arch Otolaryngol Head Neck Surg, 26, 1079, 10.1001/archotol.126.9.1079 Sparano, 2004, Multivariate predictors of occult neck metastasis in early oral tongue cancer, Otolaryngol Head Neck Surg, 131, 472, 10.1016/j.otohns.2004.04.008 Khuri, 2003, Primary head and neck cancer, 999 Stewart, 2003 Shah, 2008, New directions in head and neck imaging, J Surg Oncol, 97, 644, 10.1002/jso.21022 Abdel Razek, 2009, Characterization of pediatric head and neck masses with diffusion-weighted MR imaging, Eur Radiol, 19, 201, 10.1007/s00330-008-1123-6 Srinivasan, 2008, Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience, Am J Neuroradiol, 29, 40, 10.3174/ajnr.A0743 Kim, 2009, Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck, Clin Cancer Res, 15, 986, 10.1158/1078-0432.CCR-08-1287 Galban, 2009, A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy, Transl Oncol, 2, 184, 10.1593/tlo.09175 Vandecaveye, 2007, Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings, Int J Radiat Oncol Biol Phys, 67, 960, 10.1016/j.ijrobp.2006.09.020 Zbaren, 2008, Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma, Curr Opin Otolaryngol Head Neck Surg, 16, 147, 10.1097/MOO.0b013e3282f702a9 Petralia, 2009, Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume, J Comput Assist Tomogr, 33, 552, 10.1097/RCT.0b013e31818d446e Gandhi, 2006, Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy, Am J Neuroradiol, 27, 101 Zima, 2007, Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?, Am J Neuroradiol, 28, 328 Hermans, 2003, Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy, Int J Radiat Oncol Biol Phys, 57, 1351, 10.1016/S0360-3016(03)00764-8 Popovtzer, 2008, Targeted gold nanoparticles enable molecular CT imaging of cancer, Nano Lett, 8, 4593, 10.1021/nl8029114 Bussink, 2010, PET-CT for response assessment and treatment adaptation in head and neck cancer, Lancet Oncol., 11, 661, 10.1016/S1470-2045(09)70353-5 Meyskens, 1992, Biomarker intermediate endpoint and cancer prevention, J Natl Cancer Inst Monogr, 13, 177 Smith, 2009, Biomarkers in dysplasia of the oral cavity: a systematic review, Oral Oncol, 45, 647, 10.1016/j.oraloncology.2009.02.006 Ferrari, 2009, Biomolecular markers in cancer of the tongue, J Oncol, 412908 Freed, 2008, Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples, Laryngoscope, 118, 61, 10.1097/MLG.0b013e31814cf389 Leethanakul, 2003, Gene discovery in oral squamous cell carcinoma through the head and neck cancer genome anatomy project: confirmation by microarray analysis, Oral Oncol, 39, 248, 10.1016/S1368-8375(02)00107-0 Chuang, 2009, Tumor cell expression of podoplanin correlates with nodal metastasis in oesophageal squamous cell carcinoma, Histol Histopathol, 24, 1021 Kawaguchi, 2008, Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy, J Clin Oncol, 26, 354, 10.1200/JCO.2007.13.4072 Papadimitrakopoulou, 2009, Cyclin D1 and cancer development in laryngeal premalignancy patients, Cancer Prev Res, 2, 14, 10.1158/1940-6207.CAPR-08-0111 2010 Boyle, 1995, European School of Oncology Advisory report to the European Commission for the Europe against cancer programme: oral carcinogenesis in Europe, Eur J Cancer B: Oral Oncol, 31B, 75, 10.1016/0964-1955(95)00007-5 Boyle, 1995, Chemoprevention and oral cancer – (more) trials and (more) tribulations, Eur J Cancer B: Oral Oncol, 31B, 1, 10.1016/0964-1955(95)00006-4 Lippman, 2009, Cancer prevention: from 1717 to milestones of past 100 years, Cancer Res, 69, 5269, 10.1158/0008-5472.CAN-09-1750 Szabo, 2008, Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy, Cancer Prev Res, 1, 321, 10.1158/1940-6207.CAPR-08-0171 Khuri, 2008, Head and neck cancer chemoprevention gets a shot in the arm, J Clin Oncol, 26, 345, 10.1200/JCO.2007.14.0913 Chong, 2005, Oral cavity cancer, Cancer Imaging, 5, S49, 10.1102/1470-7330.2005.0029 Meier, 2005, Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey, Head Neck, 27, 952, 10.1002/hed.20269 Upile, 2007, The uncertainty of the surgical margin in the treatment of head and neck cancer, Oral Oncology, 43, 321, 10.1016/j.oraloncology.2006.08.002 Prince, 1999, Squamous carcinoma of the tongue: review, Brit J Oral Maxillofac Surg, 37, 164, 10.1054/bjom.1999.0031 Batsakis, 1999, Surgical excision margins: a pathologist's perspective, Adv Anat Pathol, 6, 140, 10.1097/00125480-199905000-00002 Woolgar, 2006, Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma, Oral Oncol, 42, 229, 10.1016/j.oraloncology.2005.05.008 Chuang, 2008, Risk of second cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries, Int J Cancer, 123, 2390, 10.1002/ijc.23798 Manikantan, 2009, Making sense of post-treatment surveillance in head and neck cancer: the when and what of follow-up, Cancer Treat Rev, 10.1016/j.ctrv.2009.08.007 Bradley, 2007, Status of primary tumor surgical margins in squamous head and neck cancer: prognostic implications, Curr Opin Otolaryngol Head Neck Surg, 15, 74, 10.1097/MOO.0b013e328058670f Bilde, 2009, Molecular markers in the surgical margin of oral carcinomas, J Oral Pathol Med, 38, 72 Sinha, 2009, Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue, Head Neck, 31, 1423, 10.1002/hed.21122 Braakhuis, 2010, Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue, Oral Oncol, 46, 485, 10.1016/j.oraloncology.2010.01.019 Calabrese, 2009, Compartmental surgery in tongue tumours: description of a new surgical technique, Acta Otorhinolaryngol Italy, 29, 259 Azzarelli, 1993, Surgery in soft tissue sarcomas, Eur J Cancer, 29A, 618, 10.1016/S0959-8049(05)80165-0 Hartl, 2007, Treatment of early-stage glottic cancer by transoral laser resection, Ann Otol Rhinol Laryngol, 116, 832, 10.1177/000348940711601107 Brøndbo, 2007, Laser surgery of T1a glottic carcinomas; significance of resection margins, Eur Arch Otorhinolaryngol, 264, 627, 10.1007/s00405-006-0233-5 Sigston, 2006, Early-stage glottic cancer: oncological results and margins in laser cordectomy, Arch Otolaryngol Head Neck Surg, 132, 147, 10.1001/archotol.132.2.147 Crespo, 2006, Role of margin status in recurrence after CO2 laser endoscopic resection of early glottic cancer, Acta Otolaryngol, 126, 306, 10.1080/00016480500316985 Jackel, 2007, Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery, Laryngoscope, 117, 350, 10.1097/01.mlg.0000251165.48830.89 Ansarin, 2009, Laser surgery for early glottic cancer, Arch Otolaryngol Head Neck Surg, 135, 385, 10.1001/archoto.2009.10 Weinstein, 2007, Transoral robotic surgery: radical tonsillectomy, Arch Otolaryngol Head Neck Surg, 133, 1220, 10.1001/archotol.133.12.1220 Lee, 2010, Transoral robotic surgery of craniocervical junction and atlantoaxial spine: a cadaveric study, J Neurosurg Spine, 12, 13, 10.3171/2009.7.SPINE08928 O’Malley, 2007, Robotic skull base surgery: preclinical investigations to human clinical application, Arch Otolaryngol Head Neck Surg, 133, 1215, 10.1001/archotol.133.12.1215 O’Malley, 2007, Robotic anterior and midline skull base surgery: preclinical investigations, Int J Radiat Oncol Biol Phys, 69, S125, 10.1016/j.ijrobp.2007.06.028 Selber, 2010, Transoral robotic free flap reconstruction of oropharyngeal defects: a preclinical investigation, Plast Reconstr Surg, 125, 896, 10.1097/PRS.0b013e3181cb6568 Mukhija, 2009, Transoral robotic assisted free flap reconstruction, Otolaryngol Head Neck Surg, 140, 124, 10.1016/j.otohns.2008.09.024 Lefebvre, 2009, Surgery for laryngopharyngeal SCC in the era of organ preservation, Clin Exp Otorhinolaryngol, 2, 159, 10.3342/ceo.2009.2.4.159 Moore, 2009, Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes, Laryngoscope, 119, 2156, 10.1002/lary.20647 Iseli, 2009, Functional outcomes after transoral robotic surgery for head and neck cancer, Otolaryngol Head Neck Surg, 141, 166, 10.1016/j.otohns.2009.05.014 Park, 2009, Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer, J Laparoendosc Adv Surg Tech A, 19, 361, 10.1089/lap.2008.0320 Ozer, 2008, Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions, Laryngoscope, 118, 1613, 10.1097/MLG.0b013e3181792490 Solares, 2007, Transoral robot-assisted CO2 laser supraglottic laryngectomy: experimental and clinical data, Laryngoscope, 117, 817, 10.1097/MLG.0b013e31803330b7 Weinstein, 2007, Transoral robotic surgery: supraglottic partial laryngectomy, Ann Otol Rhinol Laryngol, 116, 19, 10.1177/000348940711600104 O’Malley, 2006, Transoral robotic surgery (TORS) for base of tongue neoplasms, Laryngoscope, 116, 1465, 10.1097/01.mlg.0000227184.90514.1a O’Malley, 2006, Transoral robotic surgery (TORS): glottic microsurgery in a canine model, J Voice, 20, 263, 10.1016/j.jvoice.2005.10.004 Hockstein, 2006, Assessment of intraoperative safety in transoral robotic surgery, Laryngoscope, 116, 165, 10.1097/01.mlg.0000199899.00479.75 Weinstein, 2005, Transoral robotic surgery: supraglottic laryngectomy in a canine model, Laryngoscope, 115, 1315, 10.1097/01.MLG.0000170848.76045.47 Lee, 2008, New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting, Semin Oncol, 35, 236, 10.1053/j.seminoncol.2008.03.003 Kam, 2007, Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients, J Clin Oncol, 25, 4873, 10.1200/JCO.2007.11.5501 Kwong, 2004, Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function, Cancer, 101, 1584, 10.1002/cncr.20552 Kam, 2004, Treatment of nasopharyngeal carcinoma with intensity modulated radiotherapy: the Hong Kong experience, Int J Radiat Oncol Biol, 60, 1440, 10.1016/j.ijrobp.2004.05.022 Wolden, 2006, Intenstiy modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience, Int J Radiat Oncol Biol Phys, 64, 57, 10.1016/j.ijrobp.2005.03.057 De Arruda, 2006, Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience, Int J Radiat Oncol Biol Phys, 64, 363, 10.1016/j.ijrobp.2005.03.006 Lin, 2003, Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study, Int J Radiat Oncol Biol Phys, 57, 61, 10.1016/S0360-3016(03)00361-4 Combs, 2006, Intensity Modulated radiotherapy (IMRT) in patients with carcinoma of the paranasal sinuses: clinical benefit for complex shaped target volume, Radiat Oncol, 1, 23, 10.1186/1748-717X-1-23 Lee, 2007, Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers, Int J Radiat Oncol Biol Phys, 459, 10.1016/j.ijrobp.2007.03.013 Studer, 2006, IMRT in hypopharyngeal tumors, Strahlenther Onkol, 182, 331, 10.1007/s00066-006-1556-2 Mizoe, 2004, Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Organizing Committee for the working group for head-and-neck cancer, Int J Radiat Oncol Biol Phys, 60, 358, 10.1016/j.ijrobp.2004.02.067 Douglas, 2000, Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy, Int J Radiation Oncol Biol Phys, 46, 551, 10.1016/S0360-3016(99)00445-9 Krull, 1996, European results in neutron therapy of malignant salivary gland tumros, Bull Cancer Radiother, 83, 125s, 10.1016/0924-4212(96)84897-3 Breteau, 2000, Use of fast neutrons in the treatment of tumors of the salivary gland: rationale, review of the literature and experience in Orleans, Cancer Radiother, 4, 181, 10.1016/S1278-3218(00)89092-7 Griffin, 1988, Neutron vs. photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC cooperative randomized study, Int J Radiat Oncol Biol Phys, 15, 1085, 10.1016/0360-3016(88)90188-5 Jereczek-Fossa, 2006, Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience, Head Neck, 28, 750, 10.1002/hed.20448 Bernier, 2004, Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, 350, 1945, 10.1056/NEJMoa032641 Bernier, 2005, Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501), Head Neck, 27, 843, 10.1002/hed.20279 Forastiere, 2003, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Engl J Med, 349, 2091, 10.1056/NEJMoa031317 Pignon, 2000, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of chemotherapy on head and neck cancer, Lancet, 355, 949, 10.1016/S0140-6736(00)90011-0 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Bonner, 2006, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 354, 567, 10.1056/NEJMoa053422 Bonner, 2006, Lancet Oncol, 7, 747, 10.1016/S1470-2045(06)70860-9 Bernier, 2007, Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?, Eur J Cancer, 43, 35, 10.1016/j.ejca.2006.08.035 Posner, 2006, Cetuximab and radiotherapy for head and neck cancer, N Engl J Med, 354, 634, 10.1056/NEJMe058306 Bonner, 2010, Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomized trial, and relation between cetuximab-induced rash and survival, Lancet Oncol, 11, 21, 10.1016/S1470-2045(09)70311-0 Domenge, 2000, Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma: French Group d’Etude des Tumeurs de la Tête et du Cou (GETTEC), Brit J Cancer, 83, 1594, 10.1054/bjoc.2000.1512 Schuller, 1988, Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group, Laryngoscope, 98, 1205, 10.1288/00005537-198811000-00011 Paccagnella, 1994, Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo, J Natl Cancer Inst, 86, 265, 10.1093/jnci/86.4.265 Vermorken, 2007, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer, N Engl J Med, 357, 1695, 10.1056/NEJMoa071028 Hitt, 2005, Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer, J Clin Oncol, 23, 8636, 10.1200/JCO.2004.00.1990 Posner, 2007, Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer, N Engl J Med, 357, 1705, 10.1056/NEJMoa070956 Bozec, 2009, Emerging Molecular targeted therapies in the treatment of head and neck cancer, Expert Opin Emerging Drugs, 14, 10.1517/14728210902997947